Urologic malignancies: A comparison of outcomes after index surgery between academic and community hospitals.

Authors

null

Jamil Syed

Yale School of Medicine, New Haven, CT

Jamil Syed , Alejandro Abello , Juan Javier-Desloges , Michael Leapman , Patrick Aloysius Kenney

Organizations

Yale School of Medicine, New Haven, CT, Yale Department of Urology, New Haven, CT, Yale University, New Haven, CT

Research Funding

Other

Background: To compare the rate of hospital based outcomes in patients with urologic malignancies who underwent surgery as part of treatment in academic and community hospitals. Methods: We reviewed the Vizient Clinical Database from September 2014 to December 2017. Vizient is a member-driven health services organization that includes ~99% of academic hospitals (AH) and more than 40 community hospitals (CH). This is a comparative database comprised of administrative billing. Data include patient demographics, readmission rates, costs, LOS, case mix index (CMI) and mortality. Patients aged ≥ 18 were included and ICD-9 and ICD-10 codes were used to identify patients with urologic malignancies who underwent surgical treatment. Chi square and student t-tests were used to compare categorical and continuous variables, respectively. Results: We identified a total of 37,628 cases. There were 33,290 (88%) procedures performed in AH and 4,330 (12%) in CH. These included radical prostatectomy (RP) 18,540, radical nephrectomy (rNx) 8,059, partial nephrectomy (pNx) (5,287), radical cystectomy (4,421), radical nephroureterectomy (rNu) (1,006), and partial cystectomy (321). There were no significant differences in 30-day readmission rates or mortality for any procedure between AH and CH. LOS was significantly lower (P<0.01) for radical cystectomy (8.83 vs 11.43 days) and RP (1.63 days vs 1.77 days) in AH, and lower in CH for rNx (4.93 vs 4.51, P: 0.03). AH had a significantly lower amount of partial cystectomies performed when compared to community centers (6.2% vs 16.2% P<0.001), and a similar number of partial nephrectomies performed (39.8% vs 38.0%, P=0.2). The mean direct cost for index admission was significantly higher in AH for rNx, pNx, rNu, and RP. Case complexity using the CMI was similar between CH and AH. Conclusions: The Vizient clinical database provides a novel resource for observational data at US hospitals. Despite academic and community hospitals having similar case complexity, direct costs were lower in community hospitals without an associated increase in readmission rates or deaths. The only clinically significant difference in length of stay was shorter stays for cystectomy in academic centers.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Urothelial Carcinoma

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 489)

DOI

10.1200/JCO.2019.37.7_suppl.489

Abstract #

489

Poster Bd #

L16

Abstract Disclosures

Similar Abstracts

Abstract

2015 Genitourinary Cancers Symposium

Hospital re-admission patterns and outcomes following major urologic cancer surgery.

First Author: Sarah Holt

First Author: Trilok Shrivastava

Abstract

2024 ASCO Genitourinary Cancers Symposium

Development of a novel machine learning-based predictive risk calculator for radical cystectomy.

First Author: Aravind Rajagopalan

Abstract

2024 ASCO Genitourinary Cancers Symposium

Hierarchical clustering analysis for predicting 30-day readmissions after major surgery for prostate cancer.

First Author: Atulya Aman Khosla